| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.38 | 2e-27 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.33 | 7e-25 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 5e-18 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.35 | 7e-14 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.25 | 7e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |